Intra-arterial Chemotherapy for Retinoblastoma: Where Do We Stand?
By:  David H. Abramson, MD, FACS
With more than six years of data, the pros and cons of intra-arterial chemo are clearer than ever before.

Performance of Retinal Procedures in Previously Vitrectomized Eyes
By:  ANKIT DESAI, MD; LEVENT AKDUMAN, MD
Unique challenges can arise in these patients.

Treatment of Pigment Epithelial Detachments in Age-related Macular Degeneration
By:  BOZHO TODORICH, MD, PhD; KATHRYN PEPPLE, MD, PhD; Prithvi Mruthyunjaya, MD
A significant cause of visual morbidity in neovascular AMD, PEDs remain a treatment challenge.

Endoscopy-assisted Vitrectomy for Severe Endophthalmitis
By:  CLAUDE R. BOSCHER, MD
In cases with initial VA limited to light perception, better visualization can make a large difference.

The Role of Widefield Angiography in the Diagnosis and Management of Retinal Vascular Disease
By:  MATTHEW M. WESSEL, MD; ANTON ORLIN, MD; Szilárd Kiss, MD

Nutrition and Retina Health
By:  STEVE LENIER, CONTRIBUTING EDITOR
AREDS taught us some things about this relationship, but there’s much left to learn.

Reduction in CME From CRVO with Biweekly Avastin-Dexamethasone
By:  MATTHEW J. WELCH, MD; CLIVE H. SELL, MD

Upfront: From the Editor-in-Chief
By:  Peter K. Kaiser, M.D.
The big picture

Subspecialty News
By:  Jerry Helzner, Senior Editor
Can anti-VEGF trigger GA?; Ocriplasmin approved for symptomatic VMA; A pill to treat wet AMD?; FDA panel endorses Argus II for RP; Study shows improvement in driver-related outcomes; and more

Letters to the Editor

Journal Club

Coding Q & A
Intravitreal injections: Keeping in compliance

Surgical Precision
By:  Steve Charles, MD, FACS, FICS
Management of proliferative vitreoretinopathy

Clinical Trial Update

Focus On
By:  JAMES KNAUB, CONTRIBUTING EDITOR
Shining the light on retinal video

Calendar of Events